Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Dec;37(12):3946-51.
doi: 10.1128/JCM.37.12.3946-3951.1999.

Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species

S Arikan  1 , M Lozano-Chiu, V Paetznick, S Nangia, J H Rex
Affiliations

Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species

S Arikan et al. J Clin Microbiol. 1999 Dec.

Abstract

We compared the activities of amphotericin B, itraconazole, and voriconazole against clinical Aspergillus (n = 82) and Fusarium (n = 22) isolates by a microdilution method adopted from the National Committee for Clinical Laboratory Standards (NCCLS-M27A). RPMI 1640 (RPMI), RPMI 1640 supplemented to 2% glucose (RPMI-2), and antibiotic medium 3 supplemented to 2% glucose (AM3) were used as test media. MICs were determined after 24, 48, and 72 h. A narrow range of amphotericin B MICs was observed for Aspergillus isolates, with minor variations among species. MICs for Fusarium isolates were higher than those for Aspergillus isolates. MICs of itraconazole were prominently high for two previously defined itraconazole-resistant Aspergillus fumigatus isolates and Fusarium solani. Voriconazole showed good in vitro activity against itraconazole-resistant isolates, but the MICs of voriconazole for F. solani were high. RPMI was the most efficient medium for detection of itraconazole-resistant isolates, followed by RPMI-2. While the significance remains unclear, AM3 lowered the MICs, particularly those of amphotericin B.

PubMed Disclaimer

References

    1. Abruzzo G K, Flattery A M, Gill C J, Kong L, Smith J G, Pikounis V B, Balkovec J M, Bouffard A F, Dropinski J F, Rosen H, Kropp H, Bartizal K. Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother. 1997;41:2333–2338. - PMC - PubMed
    1. Arikan S, Lozano-Chiu M, Paetznick V, Nangia S, Rex J H. Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C: American Society for Microbiology; 1998. Activity of amphotericin B (AMB), itraconazole (ITR), and voriconazole (VOR) against Aspergillus (ASP) and Fusarium (FUS), abstr., J-19; p. 456.
    1. Denning D W, Radford S A, Oakley K L, Hall L, Johnson E M, Warnock D W. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J Antimicrob Chemother. 1997;40:401–414. - PubMed
    1. Denning D W, Venkateswarlu K, Oakley K L, Anderson M J, Manning N J, Stevens D A, Warnock D W, Kelly S L. Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother. 1997;41:1364–1368. - PMC - PubMed
    1. Dupont B, Drouhet E. Early experience with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results. Rev Infect Dis. 1987;9:S71–S76. - PubMed

Publication types

MeSH terms

LinkOut - more resources